Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Anetoderma Associated With a Succinate Dehydrogenase Gene Mutation: A Potential Link Between Anetoderma and Citric Acid Cycle Mutations.

Brys AK, Rodriguez-Homs LG, Wennerberg S, Hall RP, Nicholas MW.

JAMA Dermatol. 2019 Sep 4. doi: 10.1001/jamadermatol.2019.2579. [Epub ahead of print] No abstract available.

PMID:
31483444
2.

Induction of hair follicle neogenesis with cultured mouse dermal papilla cells in de novo regenerated skin tissues.

Zhang L, Wang WH, Jin JY, Degan S, Zhang GQ, Erdmann D, Hall RP, Zhang JY.

J Tissue Eng Regen Med. 2019 Sep;13(9):1641-1650. doi: 10.1002/term.2918. Epub 2019 Jul 15.

PMID:
31216101
3.

Stephen I. Katz MD PhD 1941-2019.

Stanley JR, Hall RP 3rd.

Br J Dermatol. 2019 May;180(5):1268-1269. doi: 10.1111/bjd.17787. No abstract available.

PMID:
31025754
4.

High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.

Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, Rao CL, Hall RP 3rd, Chao NJ, Cardones AR.

Br J Dermatol. 2019 Oct;181(4):869-871. doi: 10.1111/bjd.18028. Epub 2019 Aug 18. No abstract available.

PMID:
31017659
5.

Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.

Cardones AR, Sullivan KM, Green C, Chao NJ, Rowe-Nichols K, Bañez LL, Burton CS, Horwitz ME, Long GD, Rao CL, Sarantopoulos S, Sidhu-Malik N, Sung AD, Hall RP 3rd.

JAMA Dermatol. 2019 Jul 1;155(7):833-837. doi: 10.1001/jamadermatol.2018.5459.

PMID:
30994873
6.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

7.

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.

Agarwal A, Hall RP 3rd, Bañez LL, Cardones AR.

PLoS One. 2018 Sep 25;13(9):e0198074. doi: 10.1371/journal.pone.0198074. eCollection 2018.

8.

Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.

Marano AL, Clarke JM, Morse MA, Shah A, Barrow W, Selim MA, Hall RP 3rd, Cardones AR.

Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.

PMID:
30244487
9.

Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study.

Carpenter DJ, Sajisevi MB, Chapurin N, Brown CS, Cheng T, Palmer GM, Stevenson DS, Rao CL, Hall RP, Woodard CR.

Lasers Surg Med. 2018 Mar;50(3):246-252. doi: 10.1002/lsm.22786. Epub 2018 Jan 13.

10.

Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid.

Lin L, Hwang BJ, Culton DA, Li N, Burette S, Koller BH, Messingham KA, Fairley JA, Lee JJ, Hall RP, An L, Diaz LA, Liu Z.

J Invest Dermatol. 2018 May;138(5):1032-1043. doi: 10.1016/j.jid.2017.11.031. Epub 2017 Dec 12.

PMID:
29246800
11.

Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?

Cardones AR, Hall RP.

Br J Dermatol. 2017 Nov;177(5):1145-1147. doi: 10.1111/bjd.15890. No abstract available.

PMID:
29192991
12.

Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid.

Labowsky MT, Stinnett SS, Liss J, Daluvoy M, Hall RP 3rd, Shieh C.

Am J Ophthalmol. 2017 Nov;183:48-55. doi: 10.1016/j.ajo.2017.08.009. Epub 2017 Aug 30.

PMID:
28860044
13.

The SID Is 80 Years Old ….and Just Getting Started.

Hall RP 3rd.

J Invest Dermatol. 2017 Aug;137(8):1599-1600. doi: 10.1016/j.jid.2017.06.004. No abstract available.

14.

TRPV4 Moves toward Center-Fold in Rosacea Pathogenesis.

Chen Y, Moore CD, Zhang JY, Hall RP 3rd, MacLeod AS, Liedtke W.

J Invest Dermatol. 2017 Apr;137(4):801-804. doi: 10.1016/j.jid.2016.12.013.

15.

Pit Latrine Fecal Sludge Resistance Using a Dynamic Cone Penetrometer in Low Income Areas in Mzuzu City, Malawi.

Chirwa CF, Hall RP, Krometis LH, Vance EA, Edwards A, Guan T, Holm RH.

Int J Environ Res Public Health. 2017 Feb 3;14(2). pii: E87. doi: 10.3390/ijerph14020087.

16.

Redefining the roles of apoptotic factors in carcinogenesis.

Liu X, He Y, Li F, Huang Q, Kato TA, Hall RP, Li CY.

Mol Cell Oncol. 2015 Jun 10;3(3):e1054550. doi: 10.1080/23723556.2015.1054550. eCollection 2016 May.

17.

Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch.

Chen Y, Fang Q, Wang Z, Zhang JY, MacLeod AS, Hall RP, Liedtke WB.

J Biol Chem. 2016 May 6;291(19):10252-62. doi: 10.1074/jbc.M116.716464. Epub 2016 Mar 9.

18.

Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care.

Cardones AR, Hall RP 3rd.

JAMA Dermatol. 2016 Jun 1;152(6):629-30. doi: 10.1001/jamadermatol.2015.5241. No abstract available.

PMID:
26864990
19.

Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?

Johnson MG, Bialas RW, Hall RP, Stout JE.

J Dermatolog Treat. 2016 Aug;27(4):378-80. doi: 10.3109/09546634.2015.1115815. Epub 2015 Dec 10.

20.

Opportunistic cutaneous fungal infections in the inpatient setting.

Hooten JN, Hall RP 3rd, Cardones AR, Cheng R, Selim MA.

Int J Dermatol. 2016 Apr;55(4):e223-6. doi: 10.1111/ijd.13059. Epub 2015 Nov 17. No abstract available.

PMID:
26578311
21.

Caspase-3 promotes genetic instability and carcinogenesis.

Liu X, He Y, Li F, Huang Q, Kato TA, Hall RP, Li CY.

Mol Cell. 2015 Apr 16;58(2):284-96. doi: 10.1016/j.molcel.2015.03.003. Epub 2015 Apr 9.

22.

Reshaping the treatment of autoimmune blistering diseases: from consensus guidelines to prospective data from 'the crowd'.

Cardones AR, Hall RP.

Br J Dermatol. 2015 Apr;172(4):845-6. doi: 10.1111/bjd.13734. No abstract available.

PMID:
25827726
23.

RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation.

Zhang X, Jin JY, Wu J, Qin X, Streilein R, Hall RP, Zhang JY.

J Invest Dermatol. 2015 Apr;135(4):1016-1024. doi: 10.1038/jid.2014.519. Epub 2014 Dec 16.

24.

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP.

J Am Acad Dermatol. 2015 Jan;72(1):168-74. doi: 10.1016/j.jaad.2014.08.024. Epub 2014 Nov 4. Review.

25.

A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.

Hall RP 3rd, Fairley J, Woodley D, Werth VP, Hannah D, Streilein RD, McKillip J, Okawa J, Rose M, Keyes-Elstein LL, Pinckney A, Overington A, Wedgwood J, Ding L, Welch B.

Br J Dermatol. 2015 Mar;172(3):760-8. doi: 10.1111/bjd.13350. Epub 2015 Feb 5.

26.

Keratinocyte growth regulation TRP-ed up over downregulated TRPV4?

Liedtke W, Zhang JY, Hall RP 3rd, Steinhoff M.

J Invest Dermatol. 2014 Sep;134(9):2310-2312. doi: 10.1038/jid.2014.250.

27.
28.

Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).

Ronaghy A, Streilein RD, Hall RP 3rd.

J Dermatol Sci. 2014 Apr;74(1):93-4. doi: 10.1016/j.jdermsci.2013.11.014. Epub 2013 Dec 25. No abstract available.

PMID:
24461673
29.

The human right to water: the importance of domestic and productive water rights.

Hall RP, Van Koppen B, Van Houweling E.

Sci Eng Ethics. 2014 Dec;20(4):849-68. doi: 10.1007/s11948-013-9499-3. Epub 2013 Dec 12.

30.

Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.

Hall RP 3rd, Streilein RD, Hannah DL, McNair PD, Fairley JA, Ronaghy A, Edhegard KD, Levesque MC.

J Invest Dermatol. 2013 Dec;133(12):2786-2788. doi: 10.1038/jid.2013.236. Epub 2013 Jun 3. No abstract available.

31.

Effects of Y27632 on keratinocyte procurement and wound healing.

Gandham VD, Maddala RL, Rao V, Jin JY, Epstein DL, Hall RP, Zhang JY.

Clin Exp Dermatol. 2013 Oct;38(7):782-6. doi: 10.1111/ced.12067. Epub 2013 May 16.

32.

Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals - results from four years' clinical application for over 8,700 patients.

Ahn JW, Bint S, Bergbaum A, Mann K, Hall RP, Ogilvie CM.

Mol Cytogenet. 2013 Apr 5;6(1):16. doi: 10.1186/1755-8166-6-16.

33.

CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.

Ke H, Augustine CK, Gandham VD, Jin JY, Tyler DS, Akiyama SK, Hall RP, Zhang JY.

J Invest Dermatol. 2013 Jan;133(1):221-9. doi: 10.1038/jid.2012.253. Epub 2012 Jul 26.

34.

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

DiLillo DJ, Weinberg JB, Yoshizaki A, Horikawa M, Bryant JM, Iwata Y, Matsushita T, Matta KM, Chen Y, Venturi GM, Russo G, Gockerman JP, Moore JO, Diehl LF, Volkheimer AD, Friedman DR, Lanasa MC, Hall RP, Tedder TF.

Leukemia. 2013 Jan;27(1):170-82. doi: 10.1038/leu.2012.165. Epub 2012 Jul 13.

35.

Management of dermatitis herpetiformis.

Cardones AR, Hall RP 3rd.

Immunol Allergy Clin North Am. 2012 May;32(2):275-81, vi-vii. doi: 10.1016/j.iac.2012.04.007. Epub 2012 Apr 18. Review.

PMID:
22560140
36.

Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.

Cardones AR, Hall RP 3rd.

Immunol Allergy Clin North Am. 2012 May;32(2):263-74, vi. doi: 10.1016/j.iac.2012.04.006.

PMID:
22560139
37.

Happy birthday, Society for Investigative Dermatology.

Pentland AP, Hall RP, Yancey KB.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):495. doi: 10.1038/jid.2011.491. No abstract available.

38.

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP.

J Am Acad Dermatol. 2012 Mar;66(3):479-85. doi: 10.1016/j.jaad.2011.06.032. Epub 2011 Nov 5.

39.

Management of dermatitis herpetiformis.

Cardones AR, Hall RP 3rd.

Dermatol Clin. 2011 Oct;29(4):631-5. doi: 10.1016/j.det.2011.06.015. Epub 2011 Aug 3. Review.

PMID:
21925009
40.

Evidence-based management of bullous pemphigoid.

Daniel BS, Borradori L, Hall RP 3rd, Murrell DF.

Dermatol Clin. 2011 Oct;29(4):613-20. doi: 10.1016/j.det.2011.06.003. Epub 2011 Aug 6. Review.

PMID:
21925006
41.

Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.

Cardones AR, Hall RP 3rd.

Dermatol Clin. 2011 Jul;29(3):469-77, x. doi: 10.1016/j.det.2011.03.005. Review.

PMID:
21605814
42.

c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Jin JY, Ke H, Hall RP, Zhang JY.

J Invest Dermatol. 2011 May;131(5):1149-58. doi: 10.1038/jid.2011.1. Epub 2011 Feb 3. Erratum in: J Invest Dermatol. 2011 Jun;131(6):1388.

43.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF.

Blood. 2011 Jan 13;117(2):530-41. doi: 10.1182/blood-2010-07-294249. Epub 2010 Oct 20.

44.

The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY.

Cancer Res. 2010 Apr 15;70(8):3080-8. doi: 10.1158/0008-5472.CAN-09-2923. Epub 2010 Mar 30.

45.

Genetic, genomic and physiological state studies on single-needle bio-electrosprayed human cells.

Hall RP, Ogilvie CM, Aarons E, Jayasinghe SN.

Analyst. 2008 Oct;133(10):1347-51. doi: 10.1039/b806901h. Epub 2008 Jul 2.

PMID:
18810280
46.

A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation.

Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR.

J Am Acad Dermatol. 2008 Sep;59(3):418-25. doi: 10.1016/j.jaad.2008.05.004. Epub 2008 Jul 7.

PMID:
18603326
47.

An Evaluation of the Effectiveness of a Semi-automatic Metaphase Locating and On-screen Karyotyping System.

May PC, Ogilvie CM, Mohammed S, Docherty Z, Hall RP.

J Assoc Genet Technol. 2008;34(4):177-87.

PMID:
20081315
48.

Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin.

Berkowitz P, Diaz LA, Hall RP, Rubenstein DS.

J Invest Dermatol. 2008 Mar;128(3):738-40. Epub 2007 Oct 11. No abstract available.

49.

Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis.

Stryjewski ME, Hall RP, Chu VH, Kanafani ZA, O'Riordan WD, Weinstock MS, Stienecker RS, Streilein R, Dorschner RA, Fowler VG Jr, Corey GR, Gallo RL.

J Infect Dis. 2007 Nov 1;196(9):1425-30. Epub 2007 Sep 27.

PMID:
17922409
50.

Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten.

Hall RP 3rd, Benbenisty KM, Mickle C, Takeuchi F, Streilein RD.

J Invest Dermatol. 2007 Sep;127(9):2158-65. Epub 2007 Jun 28.

Supplemental Content

Support Center